Follow
Masha Niv
Masha Niv
Verified email at mail.huji.ac.il - Homepage
Title
Cited by
Cited by
Year
More than smell—COVID-19 is associated with severe impairment of smell, taste, and chemesthesis
V Parma, K Ohla, MG Veldhuizen, MY Niv, CE Kelly, AJ Bakke, ...
Chemical senses 45 (7), 609-622, 2020
5162020
Allostery in its many disguises: from theory to applications
SJ Wodak, E Paci, NV Dokholyan, IN Berezovsky, A Horovitz, J Li, ...
Structure 27 (4), 566-578, 2019
3072019
BitterDB: a database of bitter compounds
A Wiener, M Shudler, A Levit, MY Niv
Nucleic acids research 40 (D1), D413-D419, 2012
2712012
PDZBase: a protein–protein interaction database for PDZ-domains
T Beuming, L Skrabanek, MY Niv, P Mukherjee, H Weinstein
Bioinformatics 21 (6), 827-828, 2005
2462005
Recent smell loss is the best predictor of COVID-19 among individuals with recent respiratory symptoms
RC Gerkin, K Ohla, MG Veldhuizen, PV Joseph, CE Kelly, AJ Bakke, ...
Chemical senses 46, 2021
196*2021
Structural requirements of bitter taste receptor activation
A Brockhoff, M Behrens, MY Niv, W Meyerhof
Proceedings of the National Academy of Sciences 107 (24), 11110-11115, 2010
1942010
BitterDB: taste ligands and receptors database in 2019
A Dagan-Wiener, A Di Pizio, I Nissim, MS Bahia, N Dubovski, E Margulis, ...
Nucleic Acids Research 47 (D1), D1179-D1185, 2019
1732019
Bitter or not? BitterPredict, a tool for predicting taste from chemical structure
A Dagan-Wiener, I Nissim, N Ben Abu, G Borgonovo, A Bassoli, MY Niv
Scientific Reports 7 (1), 12074, 2017
1322017
Recurrent inactivating RASA2 mutations in melanoma
R Arafeh, N Qutob, R Emmanuel, A Keren-Paz, J Madore, A Elkahloun, ...
Nature genetics 47 (12), 1408-1410, 2015
1242015
The bitter pill: clinical drugs that activate the human bitter taste receptor TAS2R14
A Levit, S Nowak, M Peters, A Wiener, W Meyerhof, M Behrens, MY Niv
The FASEB Journal 28 (3), 1181-1197, 2014
1242014
Onset, duration and unresolved symptoms, including smell and taste changes, in mild COVID-19 infection: a cohort study in Israeli patients
H Klein, K Asseo, N Karni, Y Benjamini, R Nir-Paz, M Muszkat, S Israel, ...
Clinical Microbiology and Infection 27 (5), 769-774, 2021
109*2021
Homology modeling of G-protein-coupled receptors with X-ray structures on the rise
T Yarnitzky, A Levit, MY Niv
Curr Opin Drug Discov Devel 13 (3), 317-325, 2010
1092010
The human bitter taste receptor TAS2R10 is tailored to accommodate numerous diverse ligands
S Born, A Levit, MY Niv, W Meyerhof, M Behrens
Journal of Neuroscience 33 (1), 201-213, 2013
1082013
Peptidic modulators of protein‐protein interactions: progress and challenges in computational design
M Rubinstein, MY Niv
Biopolymers: Original Research on Biomolecules 91 (7), 505-513, 2009
1072009
Molecular determinants for the complex binding specificity of the PDZ domain in PICK1
KL Madsen, T Beuming, MY Niv, C Chang, KK Dev, H Weinstein, ...
Journal of Biological Chemistry 280 (21), 20539-20548, 2005
1052005
Promiscuity and selectivity of bitter molecules and their receptors
A Di Pizio, MY Niv
Bioorganic & medicinal chemistry 23 (14), 4082-4091, 2015
972015
The taste of toxicity: A quantitative analysis of bitter and toxic molecules
I Nissim, A Dagan‐Wiener, MY Niv
IUBMB life 69 (12), 938-946, 2017
902017
A follow-up on quantitative and qualitative olfactory dysfunction and other symptoms in patients recovering from COVID-19 smell loss
K Ohla, MG Veldhuizen, T Green, ME Hannum, AJ Bakke, ST Moein, ...
Rhinology, 2022
86*2022
A flexible docking procedure for the exploration of peptide binding selectivity to known structures and homology models of PDZ domains
MY Niv, H Weinstein
Journal of the American Chemical Society 127 (40), 14072-14079, 2005
862005
Comparing Class A GPCRs to bitter taste receptors: Structural motifs, ligand interactions and agonist-to-antagonist ratios
A Di Pizio, A Levit, M Slutzki, M Behrens, R Karaman, MY Niv
Methods in cell biology 132, 401-427, 2016
842016
The system can't perform the operation now. Try again later.
Articles 1–20